Development of a Nanoparticle-Embedded Chitosan Sponge for Topical and Local Administration of Chemotherapeutic Agents

Journal of Nanotechnology in Engineering and Medicine
Manijeh GoldbergRobert Langer

Abstract

The following work describes the development of a novel noninvasive transmucosal drug delivery system, the chitosan sponge matrix (CSM). It is composed of cationic chitosan (CS) nanoparticles (NPs) that encapsulate cisplatin (CDDP) embedded within a polymeric mucoadhesive CS matrix. CSM is designed to swell up when exposed to moisture, facilitating release of the NPs via diffusion across the matrix. CSM is intended to be administered topically and locally to mucosal tissues, with its initial indication being oral cancer (OC). Currently, intravenous (IV) administered CDDP is the gold standard chemotherapeutic agent used in the treatment of OC. However, its clinical use has been limited by its renal and hemotoxicity profile. We aim to locally administer CDDP via encapsulation in CS NPs and deliver them directly to the oral cavity with CSM. It is hypothesized that such a delivery device will greatly reduce any systemic toxicity and increase antitumor efficacy. This paper describes the methods for developing CSM and maintaining the integrity of CDDP NPs embedded in the CSM.

References

Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·F P HarmersJ P Neijt
Jan 1, 1984·Nutrition and Cancer·O OdukoyaG Shklar
Jan 1, 1981·Biopharmaceutics & Drug Disposition·D F Long, A J Repta
Oct 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D C IhdeJ C Phares
Dec 1, 1996·International Journal of Radiation Oncology, Biology, Physics·J M BachaudN Daly-Schveitzer
Oct 2, 1998·Pharmaceutical Research·L Illum
Dec 20, 1999·Pharmaceutical Research·R Fernández-UrrusunoM J Alonso
Aug 2, 2001·Current Pharmaceutical Biotechnology·S SenelC Squier
Feb 15, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R PearceyD Tu
Oct 20, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Sunil A AgnihotriTejraj M Aminabhavi
Mar 4, 2005·Chemistry : a European Journal·Justin Kai-Chi Lau, Dirk V Deubel
Jun 14, 2005·Biomaterials·Thomas FreierMolly S Shoichet
May 29, 2007·Advanced Drug Delivery Reviews·Ho Lun WongXiao Yu Wu
May 10, 2008·Journal of Microencapsulation·Crispin R Dass, Peter F M Choong
Sep 6, 2011·Oncogene·L GalluzziG Kroemer
Apr 7, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Marcos Garcia-Fuentes, Maria J Alonso

❮ Previous
Next ❯

Citations

Jan 17, 2016·Artificial Cells, Nanomedicine, and Biotechnology·Farideh MohammadianNosratollah Zarghami
Feb 13, 2018·BioImpacts : BI·Marziyeh FathiYadollah Omidi
Jan 13, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Riham O BakrSameh S Gad
Apr 11, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Annalisa RossoGiovanna Lollo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.